Cera announces new citrus ready-to-drink oral rehydration solution

Cera Products is proud to announce its new CeraLyte-70 Citrus Ready to Drink in a 500 ml environmentally green container with a re-closeable top and a long shelf-life. No mixing is needed, saving health care staff time when fast patient hydration is needed.

CeraLyte-70 Ready to Drink provides all the benefits of the powder, ready-to-mix CeraLyte-70, which is used by millions around the world. CeraLyte oral rehydration solution (ORS) is unique because it is rice-based instead of sugar or glucose-based. Its dual action replaces and reduces fluid losses by up to 50 percent. Cera's patented rice process provides mixed chain carbohydrates that quickly deliver salts and water that are a close match to what the body has lost, instead of a quick, short-chain delivery or insulin spike that comes from sugar-based products.

CeraLyte-70 is excellent for medical conditions that are accompanied by or at risk for diarrhea and dehydration, including Crohn's and colitis, short-gut syndrome, HIV/AIDS, cancer, post-antibiotic diarrhea, c-difficile, norovirus and food-borne illnesses, such as e-coli and campylobacter.

Rehydration by mouth, instead of IV line hydration is the optimal approach, not only saving the discomfort of line infection, which contributes to increased patient satisfaction, but completely eliminating the risks of line infection and generally preventing many care complications.

CeraLyte® Benefits include:

  • Prevents and corrects dehydration without IV
  • Replaces and reduces fluid losses quickly
  • Enhanced absorption due to low osmolarity
  • Safe and effective for any type of diarrhea in children or adults, including the elderly
  • Low glycemic index to avoid insulin spiking

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Promising new treatment strategy for type 2 diabetes